FXIII-A	coagulation factor XIII subunit A
BCP	B-cell progenitor
ALL	acute lymphoblastic leukemia
BFM ALL-IC 2009	Berlin-Frankfurt-Münster inter-Continental 2009 clinical trial
iBFM-SG	international Berlin-Frankfurt-Münster Study Group
EFS	event-free survival
OS	overall survival
COG	Children’s Oncology Group
WBC	white blood cell count
ic	Intracellular
FC	flow cytometry
MRD	minimal residual disease
BM	bone marrow
MLPA	multiplex ligation dependent probe amplification
CNA	copy number alterations
AIEOP-BFM 2009	International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia clinical trial
cyFXIII-A	cytoplasmic coagulation factor XIII subunit A
PB	peripheral blood
HR	high-risk
IR	intermediate risk
SR	standard risk
FLR	flow low-risk
FMR	flow medium-risk
FHR	flow high-risk
BFM-HR	BFM-high risk
BFM-SR	BFM standrard risk
BFM-IR	BFM intermediate risk
CCG	Children’s cancer group
Mtx	Methotrexate
FITC	fluorescent isotihocyanate
FISH	fluorescence in situ hybridization
CI	cinfidence intervals
HR	Hazard-ratio
CCC	clear cell carcinomas
APL	acute promyelocytic leukemia
PGR	prednisone good response
PPR	prednisone poor response
OR	Odds ratio
NA	not available
N	Number